255 related articles for article (PubMed ID: 2083493)
1. Neuropsychology of early-treated phenylketonuria: specific executive function deficits.
Welsh MC; Pennington BF; Ozonoff S; Rouse B; McCabe ER
Child Dev; 1990 Dec; 61(6):1697-713. PubMed ID: 2083493
[TBL] [Abstract][Full Text] [Related]
2. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
3. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
Diamond A
Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
[TBL] [Abstract][Full Text] [Related]
5. Executive functioning in children and adolescents with phenylketonuria.
VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
[TBL] [Abstract][Full Text] [Related]
6. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
Sharman R; Sullivan K; Young R; McGill J
Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
[TBL] [Abstract][Full Text] [Related]
7. Neuropsychological function in mild hyperphenylalaninemia.
Smith ML; Saltzman J; Klim P; Hanley WB; Feigenbaum A; Clarke JT
Am J Ment Retard; 2000 Mar; 105(2):69-80. PubMed ID: 10755172
[TBL] [Abstract][Full Text] [Related]
8. Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria.
White DA; Nortz MJ; Mandernach T; Huntington K; Steiner RD
J Int Neuropsychol Soc; 2002 Jan; 8(1):1-11. PubMed ID: 11843066
[TBL] [Abstract][Full Text] [Related]
9. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
[TBL] [Abstract][Full Text] [Related]
10. A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of "safe" levels.
Sharman R; Sullivan K; Young R; McGill J
Dev Neuropsychol; 2010; 35(1):57-65. PubMed ID: 20390592
[TBL] [Abstract][Full Text] [Related]
11. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
Seashore MR; Friedman E; Novelly RA; Bapat V
Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322
[TBL] [Abstract][Full Text] [Related]
12. [Psychometry and psychological observations in early treated children with phenylketonuria (PKU) during 12 years (author's transl)].
Knoll E; Wehle E; Thalhammer O
Klin Padiatr; 1980 Nov; 192(6):599-607. PubMed ID: 7194401
[TBL] [Abstract][Full Text] [Related]
13. Neuropsychological deficits in early treated phenylketonuric children.
Pennington BF; van Doorninck WJ; McCabe LL; McCabe ER
Am J Ment Defic; 1985 Mar; 89(5):467-74. PubMed ID: 3993693
[TBL] [Abstract][Full Text] [Related]
14. Executive functioning, memory, and learning in phenylketonuria.
Channon S; German E; Cassina C; Lee P
Neuropsychology; 2004 Oct; 18(4):613-20. PubMed ID: 15506828
[TBL] [Abstract][Full Text] [Related]
15. Psychoeducational findings among children treated for phenylketonuria.
Fishler K; Azen CG; Henderson R; Friedman EG; Koch R
Am J Ment Defic; 1987 Jul; 92(1):65-73. PubMed ID: 3618658
[TBL] [Abstract][Full Text] [Related]
16. [Effect of dietary non-compliance on development in phenylketonuria--studies of 14-year-old patients].
Theile H; Graustein I; Wässer S; Bührdel P
Padiatr Padol; 1990; 25(1):19-23. PubMed ID: 2326088
[TBL] [Abstract][Full Text] [Related]
17. Social quotients of children with phenylketonuria before and after discontinuation of dietary therapy.
Matthews WS; Barabas G; Cusack E; Ferrari M
Am J Ment Defic; 1986 Jul; 91(1):92-4. PubMed ID: 3740120
[TBL] [Abstract][Full Text] [Related]
18. Support for an independent familial segregation of executive and intelligence endophenotypes in ADHD families.
Rommelse NN; Altink ME; Oosterlaan J; Buschgens CJ; Buitelaar J; Sergeant JA
Psychol Med; 2008 Nov; 38(11):1595-606. PubMed ID: 18261248
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory control in children with phenylketonuria.
Christ SE; Steiner RD; Grange DK; Abrams RA; White DA
Dev Neuropsychol; 2006; 30(3):845-64. PubMed ID: 17083296
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
